Scancell Share Discussion Threads

[inanaco] 31/7/2023 07:18

Repeat again

Modi1 works ....... we have killer CD4 t cells

now we shape the environment to give them the best chance

we are in control because we have the "working element"

and for the first time in a few months a "direct look" inside the cancer to see exactly what is going on

its a fantastic trial in that it covers all bases

with the backdrop now, we know we have some synergy with SCIB1 .... and checkpoints with 73% of that trial recruited ....

[pal44] 31/7/2023 07:14

Good news this morning

[marcusl2] 31/7/2023 07:12

As expected and hoped that Modi-1 will work best at Cohort 4 (High Dose plus CPI) ;

1st patient on High Dose plus CPI...... Tumour Regression


Excellent news.

[inanaco] 31/7/2023 07:02

The Doomsters buy back begins ....

[markingtime] 31/7/2023 07:00

Good news today. If more than just the first patient shows tumour shrinkage then it could fly.Something must be going right to get approval for a bigger-than-expected expansion (don't think the surgery candidates were expected just yet?).

[chillpill] 31/7/2023 06:22

No negatives in there! Glad I topped up.

All the major immunotherapy companies willbe watching very carefully.

[miavoce] 31/7/2023 06:14

First (and so far the only) patient assessed in cohort 4 has shown tumour regression - sounds promising...

[pharmaboy3] 31/7/2023 06:05

NewsHTTps://www.voxmarkets.co.uk/rns/announcement/74bdac01-3abb-4621-af29-8e08f4854017/

[ivyspivey] 28/7/2023 15:32

Yep 2tyke.
Cracking trade on CPX to take away the boredom of being here after missing out on some of the mega risers this week.
Enjoy the w/ end all

[1knocker] 28/7/2023 12:18

'thanks' Tyke? 'writers' rather than 'writer's'? You seem to have as much difficulty with English as you do with [fantasy] charts!

[2tyke] 28/7/2023 11:32

Lol...someone thanks ratcliffe writers post is great !
I think quite possibly I've heard it all now !
Lollollol

[marcusl2] 28/7/2023 08:11

OK, Milan is confirmed at least.

CRI-ENCI-AACR SEVENTH INTERNATIONAL CANCER IMMUNOTHERAPY CONFERENCE: TRANSLATING SCIENCE INTO SURVIVAL
September 20-23, 2023
Allianz MiCo
Milano, Italy

The platform has generated revenues and the antibodies continue to yield compelling results which have led to a new 6-month evaluation by a leading Biotech company. Additional in-house data has illustrated the potential of our antibodies as chimeric antigen receptor T cell (CART) therapies providing the data for a deal with a cell therapy company. These results along with updates on SCIB1 and Modi-1 will be presented at the AACR-CIMT meeting in Milan in September 2023.

[ivyspivey] 28/7/2023 08:00

Hi Marcus,
Someone else has pointed out to me that the title Joint CEO is way out of date and they think in previous years she appeared on the speakers list but did not actually speak.

[2tyke] 28/7/2023 07:32

Confusion runs rampant on LSE...lol.
Can anyone explain how the share price is only 9p ? Lol.
I've done precisely that over the past several months !
The absolutely clueless 'ratcliffe writer' thinks it's either a 'sell'...or it's a "buy'...lol.
Follow the waves....they tell you the unfolding story ...something you really can 'believe'.
Science and fundamentals are for company accounts.
Fear and greed are for trading stock tickers !
Jeez....

[marcusl2] 28/7/2023 07:32

(About 13 rows down)

I presume she will be telling people about Modi-1 working well in combination with CPIs and excellent Scib-1 plus doublet data. Hopefully iScib-1 started by then.

Prof Lindy Durrant, Joint Chief Executive Officer and Cso, Scancell Ltd

[marcusl2] 28/7/2023 07:31

(About 13 rows down)

I presume she will be telling people about Modi-1 working well in combination with CPIs and excellent Scib-1 plus doublet data. Hopefully iScib-1 started by then.

Prof Lindy Durrant, Joint Chief Executive Officer and Cso, Scancell Ltd

[ivyspivey] 28/7/2023 06:41

Morning Marcus thanks for speaker link.
I downloaded the agenda but could not see LD slot in Cancer Vax so have I just missed her on agenda or do you know what she is talking about.
See Ira Mellman is talking

[marcusl2] 27/7/2023 20:46

World Vaccine Congress Europe 2023 | 16 - 19 October 2023


The region's largest event dedicated to vaccine business, science and technology development.

[1knocker] 27/7/2023 19:16

No one needs to be a 'technician', let alone a chartless chartist in order to be proved 'entirely accurate' when predicting that an share price could go up or might go down.

To be fair though, I do accept that such a prediction does have the merit of accuracy, though its usefulness is more difficult to discern. You can't make money on a two way bet on a two horse race though. But perhaps you count 'sideways movement' as a third horse in the race? Do remember that you can't make money on sideways movement either, whether you are short or long.

I do sympathise though. the RMM and Mode Global Holdings debacles will still be fresh in your memory, leading you to the [entirely accurate] conclusion that a two way bet on a two horse race, though pointless, is at least better than backing a faller.

[volsung] 27/7/2023 19:06

It was 1952
I was a young District Commissioner in Bechuanaland
Goodness it was hot!
Ngutu, my trusty servant had just located a bull elephant which had been rampaging through the local villages
I shot the buggar, the elephant, not Ngutu.
They were different times

[2tyke] 27/7/2023 19:05

Loggy...probably best to love tinnies if one follows LUFC...lol

[thelogman] 27/7/2023 19:03

TINNIES are the future, get some shop lifting done to rebel against price increases 😜😜😜👍

[thelogman] 27/7/2023 19:01

2tyke, you may be right I fell in love with my tinnies and still in denial that I can do without them😂

[2tyke] 27/7/2023 18:50

That's right Ivy.
The odds thing is that the scientists and fundamentalists have over a decade of proof that their premise on stock prices is INVARIABLY WRONG.
They still maintain that the market is actually wrong. Thus, they demonstrate ZERO intellectual honesty.
Meanwhile...a technician has come onto the bb and been proved entirely accurate...in advance of the price moves.
Like you say....why wouldn't anyone want to know more ?
The answer is a complex mix of 'falling in love' and 'denial'.